KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Long-Term Deferred Tax (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Long-Term Deferred Tax for 16 consecutive years, with $4.2 billion as the latest value for Q1 2026.

  • For Q1 2026, Long-Term Deferred Tax rose 21.73% year-over-year to $4.2 billion; the TTM value through Mar 2026 reached $4.2 billion, up 21.73%, while the annual FY2025 figure was $4.1 billion, 23.03% up from the prior year.
  • Long-Term Deferred Tax hit $4.2 billion in Q1 2026 for Regeneron Pharmaceuticals, up from $4.1 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $4.2 billion in Q1 2026 and bottomed at $1.1 billion in Q1 2022.
  • Average Long-Term Deferred Tax over 5 years is $2.7 billion, with a median of $2.8 billion recorded in 2024.
  • Year-over-year, Long-Term Deferred Tax surged 100.79% in 2022 and then rose 21.73% in 2026.
  • Regeneron Pharmaceuticals' Long-Term Deferred Tax stood at $1.7 billion in 2022, then soared by 49.41% to $2.6 billion in 2023, then increased by 28.68% to $3.3 billion in 2024, then grew by 23.03% to $4.1 billion in 2025, then increased by 2.79% to $4.2 billion in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $4.2 billion, $4.1 billion, and $3.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.